Fig. 4
From: The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer
GALNT2 knockdown inhibits the malignant properties of NSCLC cells. A Detection of GALNT2 expression by RT-qPCR. B Detection of GALNT2 expression by Western blot. C Cell proliferation assay. D Colony formation assay. E Transwell migration and Matrigel invasion assays (magnification, ×100). F Flow cytometric analysis of cell cycle. G Analysis of cell apoptosis by flow cytometry. OV GALNT2 overexpression lentivirus, Mock normal control lentivirus, shRNA GALNT2 shRNA lentivirus, shNC negative control shRNA lentivirus. *P < 0.05